We know a proactive approach is vital to knocking colon cancer out of the top three cancer killers. Scientific research is among the best ways we can go on the offensive against this disease. We conduct and support innovative research that:

  • Advances biomarker research
  • Understands why those under 50 are increasingly diagnosed with colon cancer
  • Decreases late-state diagnosis of high-risk populations
  • Closes the referral gap for screening and diagnostic testing
  • Advances long-term survivorship psychosocial concerns

We view patients, researchers, medical institutions and industry as pivotal allies for pursuing this mission.


The Salah Foundation has offered to match dollar for dollar (up to $125,000) all research-specific contributions made to the Colon Cancer Alliance. Learn how you can have your gift matched here.

We’re looking for sponsors to support critical research efforts. To learn more, please contact Nicole Sheahan, Vice President of Development, at (202) 628-0123 ext. 103 or nsheahan@ccalliance.org.

What We’re Doing

Funding Research

The Colon Cancer Alliance Blue Hope Research Award is a one-year fellowship providing critical resources and funding to some of the brightest investigators focusing on colon cancer research. This year, we focused on biomarkers and how these genetic indicators can aid in the prevention and treatment of colon cancer. Read more about the Blue Hope Research Award.

Matching Patients with Front-Line Research Trials

Programs like our Clinical Trial Matching Service connect patients to cutting-edge treatments and new colon cancer therapies. Through these clinical trials, doctors and researchers are able to develop and improve lifesaving colon cancer treatments.

Funding Local Research

Our Blue Hope Partnership Program provides funding to local community partners in cities where our Undy Run/Walk events happen.

Collaborative Research Projects

To increase screening rates and improve the quality of life for survivors, we conduct research studies on colon cancer screening barriers, treatment outcomes and survivorship issues. We have partnered with organizations and companies to conduct various types of research including national surveys, white papers and abstracts.